Skip to main content
Account

Peer review reports

From: Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma

Original Submission
8 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
31 Aug 2022 Reviewed Reviewer Report
8 Oct 2022 Reviewed Reviewer Report
4 Nov 2022 Author responded Author comments - Peter Mu-Hsin Chang
Resubmission - Version 3
4 Nov 2022 Submitted Manuscript version 3
9 Nov 2022 Author responded Author comments - Peter Mu-Hsin Chang
Resubmission - Version 4
9 Nov 2022 Submitted Manuscript version 4
14 Nov 2022 Reviewed Reviewer Report
3 Dec 2022 Reviewed Reviewer Report
6 Dec 2022 Author responded Author comments - Peter Mu-Hsin Chang
Resubmission - Version 5
6 Dec 2022 Submitted Manuscript version 5
Publishing
12 Dec 2022 Editorially accepted
20 Dec 2022 Article published 10.1186/s12885-022-10440-7

Learn about peer review

Back to article page

Navigation